31.70
-0.785(-2.42%)
Currency In USD
| Previous Close | 32.48 |
| Open | 32.35 |
| Day High | 33.16 |
| Day Low | 31.69 |
| 52-Week High | 68.44 |
| 52-Week Low | 31.69 |
| Volume | 994,011 |
| Average Volume | 2.15M |
| Market Cap | 3.79B |
| PE | -5.99 |
| EPS | -5.29 |
| Moving Average 50 Days | 41.2 |
| Moving Average 200 Days | 49.34 |
| Change | -0.79 |
If you invested $1000 in Cytokinetics, Incorporated (CYTK) 10 years ago, it would be worth $4,766.17 as of May 10, 2025 at a share price of $31.695. Whereas If you bought $1000 worth of Cytokinetics, Incorporated (CYTK) shares 5 years ago, it would be worth $1,510 as of May 10, 2025 at a share price of $31.695.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress
GlobeNewswire Inc.
May 08, 2025 8:00 PM GMT
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three Late Breaking Science presentations and one ePoster presentation at Heart Failure 2025, an International Congress of the E
Cytokinetics to Hold Annual Meeting of Stockholders
GlobeNewswire Inc.
May 07, 2025 8:00 PM GMT
SOUTH SAN FRANCISCO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 14, 2025 at 10:00 AM Pacific Time at the Company’s headqu
Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
GlobeNewswire Inc.
May 01, 2025 8:15 PM GMT
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New